Related Experiment Video
Updated: Aug 26, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Cancer: Can CRISPR Become a Game Changer?
1Department of Pathology, PNS Hafeez Naval Hospital, Islamabad, Pakistan.
Abstract:
Recent development in CRISPR technologies has emerged as a powerful tool for genome editing, which can become a powerful diagnostic and therapeutic option for cancer patients. While literature search demonstrates some successes in this dimension in animal models and phase-I human trials, still the promised panacea has shortcomings in terms of off-target mutations (OTMs), minimal efficiency, and tailoring individualised interventions. While there is a promise for the future, although the CRISPR technology still has to climb up the ladder in terms of improvements with more enhanced efficiency tools for delivering the payload into cell and reducing the off-target mutations. Key Words: CRISPR, Oncology, Off-target mutations (OTMs), Genome editing, 3-D cell cultures.
Insights
CRISPR genome editing shows promise for cancer diagnostics and therapy, but faces challenges. Further improvements are needed to enhance efficiency and reduce off-target mutations for clinical application.
Area of Science:
- Biotechnology
- Genomics
- Oncology
Background:
- CRISPR technology offers powerful genome editing capabilities with potential applications in cancer diagnostics and therapy.
- Current research shows successes in animal models and early-phase human trials for CRISPR-based cancer interventions.
Purpose of the Study:
- To review the current state of CRISPR technology in oncology.
- To identify limitations and areas for improvement in CRISPR-based cancer therapies.
Main Methods:
- Literature search and analysis of existing studies on CRISPR applications in cancer.
- Evaluation of CRISPR technology's efficacy, safety (off-target mutations), and delivery methods.
Main Results:
- CRISPR demonstrates potential in oncology but faces significant challenges.
- Key limitations include off-target mutations, variable efficiency, and difficulties in personalized treatment delivery.
Conclusions:
- CRISPR technology requires further advancements in efficiency and specificity for widespread clinical use in cancer treatment.
- Enhanced delivery systems and methods to minimize off-target mutations are crucial for realizing CRISPR's full therapeutic potential in oncology.
Related Concept Videos
CRISPR
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
What is Genetic Engineering?
Homologous Recombination
The Antiviral System of Bacteria and Archaea: CRISPR

